IL13 and Alzheimer disease: Treatment of AD patients with an anti-human IL-4Rα antibody (dupilumab) that inhibits binding of IL-4 and IL-13 to IL-4Rα improved the signs and symptoms of AD (including pruritus), anxiety and depression, as well as the quality of life, compared to placebo controls (82).